Clincosm LogoSign in Get a demo

Metastatic Solid Tumor

Showing 1 - 25 of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Nashville, Dallas, Fairfax (JZP898, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Nashville, Tennessee
  • +2 more
Oct 26, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor Trial in Australia, France, United States (BGB-A3055, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Iowa City, Iowa
  • +7 more
Jul 5, 2023

NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 16, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Jun 1, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
May 12, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +7 more
  • WM-A1-3389
  • Pembrolizumab
  • Seoul, Seocho-gu, Korea, Republic of
  • +1 more
May 14, 2023

Metastatic Solid Tumor, NSCLC, Gastric Cancer Trial (RO7496353, Atezolizumab, Capecitabine)

Not yet recruiting
  • Metastatic Solid Tumor
  • +3 more
  • (no location specified)
May 22, 2023

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

Genomic Data of American Indian Patient Population

Active, not recruiting
  • Immune Checkpoint Inhibitors
  • +6 more
  • Immunotherapy
  • Tucson, Arizona
  • +5 more
May 8, 2023

Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
May 3, 2023

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Canton, Ohio
    Gabrail Cancer Research Center
Apr 25, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (repotrectinib (TPX-0005))

Recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • repotrectinib (TPX-0005)
  • Canton, Ohio
    Gabrail Cancer Research Center
Apr 25, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Seoul (GI-102)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Seoul, Korea, Republic of
  • +3 more
Apr 20, 2023

Oncology, Chemotherapeutic Toxicity, Metastatic Solid Tumor Trial in Minneapolis (Chemotherapy toxicity tool, Oncology

Active, not recruiting
  • Oncology
  • +2 more
  • Chemotherapy toxicity tool
  • Oncology Consultation
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Mar 30, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)

Not yet recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Providence, Rhode Island
    Rhode Island Hospital, Brown University
Mar 2, 2023

Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • (no location specified)
Jan 28, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Fairfax, Virginia
    NEXT Virginia
Feb 1, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (NVL-655)

Recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Orange, California
  • +13 more
Jan 31, 2023

Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

Recruiting
  • Metastatic Solid Tumor
  • +3 more
  • 1.0% IP-001 for Injection
  • Bordeaux, France
  • +9 more
Jan 26, 2023

Advanced Cancer, Metastatic Solid Tumor, Solid Tumor Trial (TACH101)

Recruiting
  • Advanced Cancer
  • +2 more
  • Austin, Texas
    NEXT Oncology
Jan 25, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Metastatic Solid Tumor Trial in Worldwide (Sacituzumab Govitecan-hziy)

Recruiting
  • Metastatic Solid Tumor
  • Sacituzumab Govitecan-hziy
  • Anchorage, Alaska
  • +64 more
Jan 23, 2023

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023